- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on NSCLC
Total 1030 results
-
The First Affiliated Hospital of Guangzhou Medical...Unknown
-
Instituto Oncológico Dr RosellTurning Point Therapeutics, Inc.Recruiting
-
PTS International Inc.Completed
-
Newsoara Biopharma Co., Ltd.Not yet recruiting
-
Fujian Cancer HospitalNot yet recruiting
-
University Hospital, EssenRecruiting
-
Zhejiang Genfleet Therapeutics Co., Ltd.Active, not recruiting
-
Michael HoppBoehringer IngelheimActive, not recruiting
-
Peking University Cancer Hospital & InstituteEnrolling by invitationLocally Advanced NSCLCChina
-
Sichuan UniversityInnovent Biologics (Suzhou) Co. Ltd.Completed
-
Shenzhen People's HospitalEnrolling by invitation
-
Yonsei UniversityWithdrawn
-
Kiang Wu HospitalCompleted
-
Agenus Inc.Terminated
-
AstraZenecaUnknownNSCLC Patient CharacteristicsSaudi Arabia
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingLung Cancer | Non Small Cell Lung Cancer | NSCLC, Stage III | Nsclc | NSCLC Stage IIUnited States
-
Shenzhen People's HospitalUnknown
-
Stanford UniversityTerminatedLung Cancer | Mesothelioma | Lung Cancer Non-Small Cell Cancer (NSCLC) | Lung Cancer Small Cell Lung Cancer (SCLC)United States
-
ETOP IBCSG Partners FoundationTakedaRecruitingNSCLC, Stage III | ALK-rearrangementFrance, Spain, Italy, Poland, United Kingdom
-
IO BiotechMerck Sharp & Dohme LLCCompletedNSCLCUnited Kingdom, Germany, Netherlands, Spain
-
Maastricht Radiation OncologyUniversity of Pennsylvania; University of Wisconsin, MadisonCompleted
-
German Cancer Research CenterUniversity Hospital Heidelberg; National Center for Tumor Diseases, HeidelbergCompleted
-
Fujian Cancer HospitalUnknownChemotherapy Effect | NSCLC Stage IVChina
-
AstraZenecaNo longer available
-
AstraZenecaRecruiting
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Shandong Cancer Hospital and InstituteRecruitingUnresectable Stage III NSCLCChina
-
Molecular Partners AGTerminatedEGFR-mutated NSCLC (Disorder)United States
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedAdvanced or Metastatic NSCLCChina
-
Xueqin YangRecruitingNSCLC | Targeted Therapy | EvaluationChina
-
Zhejiang Cancer HospitalNot yet recruitingUnresectable Stage III NSCLC
-
Anhui Medical UniversityUnknown
-
European Organisation for Research and Treatment...Not yet recruiting
-
Shanghai Henlius BiotechRecruiting
-
NYU Langone HealthRecruitingNSCLC Stage IVUnited States
-
Zhejiang Cancer HospitalRecruiting
-
IRCCS Policlinico S. MatteoRecruiting
-
Institut für Klinische Krebsforschung IKF GmbH...AstraZeneca; Thoraxklinik-Heidelberg gGmbHRecruiting
-
Shanghai 10th People's HospitalUnknownNSCLC and TheropyChina
-
The First People's Hospital of LianyungangHengrui Yuanzheng Bio-Technology Co., Ltd.Unknown
-
Sheba Medical CenterRambam Health Care Campus; AstraZeneca; Tel-Aviv Sourasky Medical CenterRecruitingMetastatic or Locally Advanced NSCLCIsrael
-
Intergroupe Francophone de Cancerologie ThoraciqueBristol-Myers Squibb; Pierre Fabre Laboratories; Ligue contre le cancer, FranceCompleted
-
Tianjin Chest HospitalRecruitingNSCLC With COPDChina
-
Seoul National University HospitalSeoul National University Bundang Hospital; SMG-SNU Boramae Medical CenterActive, not recruitingLocally Advanced or Metastatic NSCLCKorea, Republic of
-
Shanghai Chest HospitalBristol-Myers SquibbCompletedNSCLC Stage IV | Checkpoint InhibitorChina
-
AstraZenecaCompletedLocally Advanced or Metastatic NSCLCKorea, Republic of, China, Japan
-
AstraZenecaCompleted
-
Yongchang ZhangRecruitingHER2 Insertion Mutation Positive Advanced NSCLCChina
-
ETOP IBCSG Partners FoundationAstraZenecaActive, not recruitingNSCLC Stage IV | EGFR Gene MutationSingapore, Sweden, Korea, Republic of, Spain, Switzerland, Netherlands, Italy, Poland